Analyst stock forecast
Lakewood-Amedex Biotherapeutics Forecast: $12.00 Analyst Target
Direct answer
Lakewood-Amedex Biotherapeutics's average price target is $12.00.
The target implies +943.5% from the recorded current price, and the consensus rating is none.
The low target implies +943.5%, the high target implies +943.5%, and the range spans 0% of the current price.
Forecast evidence checked September 28, 2026.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.15
- Average price target
- $12.00
- High price target
- $12.00
- Low price target
- $12.00
- Low target gap
- +943.5%
- Target upside
- +943.5%
- High target gap
- +943.5%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 28, 2026
- Valid through
- October 5, 2026
Explore related company data
Read the frequently asked questions.
What is Lakewood-Amedex Biotherapeutics's average price target?
Lakewood-Amedex Biotherapeutics's verified average price target is $12.00. The target range is $12.00 to $12.00.
How far are Lakewood-Amedex Biotherapeutics's low and high targets from the recorded price?
The low target implies +943.5%, while the high target implies +943.5%.
How many analysts are included in Lakewood-Amedex Biotherapeutics's consensus?
The verified consensus includes 1 analysts.
How is Lakewood-Amedex Biotherapeutics's target upside or downside calculated?
The average target of $12.00 is divided by the recorded price of $1.15, then one is subtracted to produce +943.5%. This does not guarantee a future return.
When was Lakewood-Amedex Biotherapeutics's analyst forecast verified?
The data was verified on 2026-09-28. The dataset is valid through 2026-10-05.